AstraZeneca Names New CEO, Faces More Competition
Aug. 28 (Bloomberg) -- Bloomberg's Erik Schatzker reports that AstraZeneca named Pascal Soriot as chief executive officer as the company faces increased generic competition. He speaks on Bloomberg Television's "Market Makers." (Source: Bloomberg)
Most Recent Videos
What Are Today's Takeaways from Trump's Actions?
17:48 - Bloomberg's Margaret Talev reports on President Donald Trump’s conversation with Canadian President Justin Trudeau and the memoranda on the Keystone XL and Dakota Access pipelines. She speaks on "What'd You Miss?" (Source: Bloomberg)